Abbott reports first-quarter 2022 results

Sales growth of 13.8 percent; organic sales growth of 17.5 percent global covid-19 testing-related sales of $3.3 billion in the first quarter excluding covid-19 testing-related sales, first-quarter reported sales growth of 3.9 percent and organic sales growth of 7.7 percent gaap diluted eps growth of 37.0 percent; adjusted diluted eps growth of 31.1 percent continues to strengthen portfolio with new product approvals and expanded reimbursement coverage abbott park, ill., april 20, 2022 /prnewswire/ -- abbott (nyse: abt) today announced financial results for the first quarter ended march 31, 2022.
ABT Ratings Summary
ABT Quant Ranking